What should be done if an Enhertu infusion reaction occurs?
“Other clinically relevant adverse reactions reported in <10% of patients treated with ENHERTU were dizziness (9%), decreased weight (7%), dry eye (7%), dyspnea (6%), blurred vision (5%), abdominal distension (4.8%), pruritus (3.9%), flatulence (2.3%), dehydration (1.6%), febrile neutropenia (1.2%), infusion-related reactions (1.2%), skin hyperpigmentation (0.9%), and gastritis (0.7%)1” (opens the source at this quote in a new tab)
Note: The second passage is from DESTINY-Breast06 (ENHERTU n=434) and includes infusion-related reactions (1.2%).